It's time to wrap up warm and dive into the icy waters of understanding weight loss injections
Theyre not right for every woman, but these are FDA-approved medications
Severe or multisystem metabolic disease: Significant obesity plus diabetes, MASLD, OSA, or clustered cardiovascular risk factors, where every extra few percentage points of weight and risk reduction matter. Patients who need maximum, not moderate, change: Those aiming for 20%plus loss to qualify for surgery, offload joints, or defuse highstakes diagnoses in a defined time window. Patients who can handle tighter structure: People willing to tolerate stronger appetite suppression, closer titration, and more lab and nutrition oversight in exchange for bigger, faster shifts in body weight and cardiometabolic markers. Who leans toward semaglutide
As of May 2026, one in five US households had at least one GLP-1 user, according to data from PwC and those shares are probably as low as they will ever be